Skip to content
10-K

Annual Report

OncoMed Pharmaceuticals Inc

0001564590-19-006795

← back to feed
Filed
Mar 7, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 5, 2019 38.69M sh
Capex FY 2018 · Dec 31, 2018 $655K
Capex FY 2018 · Dec 31, 2017 $585K
Capex FY 2018 · Dec 31, 2016 $1.16M
Operating Cash Flow FY 2018 · Dec 31, 2018 −$44.86M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$84.97M
Operating Cash Flow FY 2018 · Dec 31, 2016 −$36.94M
Short Term Investments FY 2018 · Dec 31, 2018 $47.66M
Short Term Investments FY 2018 · Dec 31, 2017 $89.81M
Cash And Equivalents FY 2018 · Dec 31, 2018 $9.69M
Cash And Equivalents FY 2018 · Dec 31, 2017 $13.28M
Cash And Equivalents FY 2018 · Dec 31, 2016 $36.95M
Cash And Equivalents FY 2018 · Dec 31, 2015 $38.44M
Stockholders Equity FY 2018 · Dec 31, 2018 $48.23M
Stockholders Equity FY 2018 · Dec 31, 2017 −$48.6M
Stockholders Equity FY 2018 · Dec 31, 2016 −$23.03M
Stockholders Equity FY 2018 · Dec 31, 2015 $3.55M
Current Liabilities FY 2018 · Dec 31, 2018 $12.64M
Current Liabilities FY 2018 · Dec 31, 2017 $93.13M
Total Liabilities FY 2018 · Dec 31, 2018 $16.85M
Total Liabilities FY 2018 · Dec 31, 2017 $158.93M
Current Assets FY 2018 · Dec 31, 2018 $63.73M
Current Assets FY 2018 · Dec 31, 2017 $105.21M
Total Assets FY 2018 · Dec 31, 2018 $65.08M
Total Assets FY 2018 · Dec 31, 2017 $110.32M
Eps Diluted FY 2018 · Dec 31, 2018 −$0.21
Eps Basic FY 2018 · Dec 31, 2018 −$0.21
Sga Expense FY 2018 · Dec 31, 2018 $18.17M
Sga Expense FY 2018 · Dec 31, 2017 $16.76M
Sga Expense FY 2018 · Dec 31, 2016 $18.83M
Rd Expense FY 2018 · Dec 31, 2018 $34.44M
Rd Expense FY 2018 · Dec 31, 2017 $59.84M
Rd Expense FY 2018 · Dec 31, 2016 $109.71M
Net Income FY 2018 · Dec 31, 2018 −$4.67M
Net Income FY 2018 · Dec 31, 2018 −$8.1M
Net Income FY 2018 · Sep 30, 2018 $6.12M
Net Income FY 2018 · Jun 30, 2018 −$3.98M
Net Income FY 2018 · Mar 31, 2018 −$5.57M
Net Income FY 2018 · Dec 31, 2017 $9.46M
Net Income FY 2018 · Dec 31, 2017 −$39.06M
Net Income FY 2018 · Sep 30, 2017 −$10.69M
Net Income FY 2018 · Jun 30, 2017 −$15.23M
Net Income FY 2018 · Mar 31, 2017 −$22.61M
Net Income FY 2018 · Dec 31, 2016 −$103.1M
Operating Income FY 2018 · Dec 31, 2018 −$10.05M
Operating Income FY 2018 · Dec 31, 2017 −$40.97M
Operating Income FY 2018 · Dec 31, 2016 −$103.39M
Revenue FY 2018 · Dec 31, 2018 $10.18M
Revenue FY 2018 · Dec 31, 2018 $44.42M
Revenue FY 2018 · Sep 30, 2018 $19.52M
Revenue FY 2018 · Jun 30, 2018 $6.87M
Revenue FY 2018 · Mar 31, 2018 $7.85M
Revenue FY 2018 · Dec 31, 2017 $20.64M
Revenue FY 2018 · Dec 31, 2017 $38.15M
Revenue FY 2018 · Sep 30, 2017 $5.11M
Revenue FY 2018 · Jun 30, 2017 $6.2M
Revenue FY 2018 · Mar 31, 2017 $6.21M
Revenue FY 2018 · Dec 31, 2016 $25.15M